Tiziana Life Sciences
TLSA
18 hedge funds and large institutions have $1.15M invested in Tiziana Life Sciences in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
4.11% less ownership
Funds ownership: 5.16% → 1.05% (-4.1%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
22% less funds holding
Funds holding: 23 → 18 (-5)
64% less capital invested
Capital invested by funds: $3.17M → $1.15M (-$2.02M)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$13.4K |
| 2 |
ZF
Zhang Financial
Portage,
Michigan
|
+$4.75K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.27K |
| 5 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
+$1.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$2.47M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23.7K |
| 3 |
Morgan Stanley
New York
|
-$16.6K |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$13.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.86K |
TLSA Hedge Fund Activity: Q1 2023 in Review
18 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q1 2023, worth a combined $1.15M — down 64% from $3.17M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of TLSA and 1 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was State Street, adding an estimated $13.4K. The largest seller was HighTower Advisors, exiting entirely with an estimated $2.47M sold.
- 18 institutional investors held Tiziana Life Sciences (TLSA) as of Q1 2023, down from 23 in Q4 2022.
- Funds reported $1.15M of Tiziana Life Sciences stock for Q1 2023, down 64% quarter-over-quarter.
- 1 fund opened new Tiziana Life Sciences positions in Q1 2023 and 6 closed out, a net change of -5 holders.
- The largest Tiziana Life Sciences buyer in Q1 2023 was State Street, an estimated $13.4K added.
- The largest Tiziana Life Sciences seller in Q1 2023 was HighTower Advisors, an estimated $2.47M sold.
Based on aggregated 13F filings for Q1 2023.